FEMASYS INC. - COMMON STOCK
1.7000
20-February-25 12:38:34
15 minutes delayed
Stocks
+0.0100
+0.59%
Today's range
1.5700 - 1.7350
ISIN
N/A
Source
NASDAQ
-
20 Jul 2022 07:00:00 By Nasdaq GlobeNewswire
-
11 Jul 2022 08:30:00 By Nasdaq GlobeNewswire
-
Femasys Inc. Announces Existing Board Member Charles Larsen as Chairperson of the Board
06 Jul 2022 08:00:01 By Nasdaq GlobeNewswire
-
Femasys Inc. to Present at the LSX World Congress USA 2022
15 Jun 2022 08:00:01 By Nasdaq GlobeNewswire
-
Femasys Inc. Announces Financial Results for the First Quarter Ended March 31, 2022
11 May 2022 16:05:01 By Nasdaq GlobeNewswire
-
Femasys Inc. to Participate in the M-Vest 2022 Virtual Growth Conference
25 Mar 2022 08:00:00 By Nasdaq GlobeNewswire
-
Femasys Inc. Announces Financial Results for the Year Ended December 31, 2021
24 Mar 2022 16:05:01 By Nasdaq GlobeNewswire
-
Femasys Inc. Announces the Appointment of Dov Elefant to New Position of Chief Financial Officer
24 Feb 2022 08:00:03 By Nasdaq GlobeNewswire
-
20 Jan 2022 08:00:03 By Nasdaq GlobeNewswire
-
Femasys Inc. to Participate in Upcoming January Investor Conferences
23 Dec 2021 08:05:00 By Nasdaq GlobeNewswire
-
Femasys Inc. Announces Financial Results for the Third Quarter of 2021
10 Nov 2021 16:05:03 By Nasdaq GlobeNewswire
-
Femasys Inc. to Present at The MedTech Conference
23 Sep 2021 17:46:39 By Nasdaq GlobeNewswire
-
Femasys Inc. To Join the Russell Microcap® Index
20 Sep 2021 16:05:00 By Nasdaq GlobeNewswire
-
Femasys Inc. Announces the Appointment of Edward Evantash, M.D. as Chief Medical Officer
01 Sep 2021 16:05:00 By Nasdaq GlobeNewswire
-
Femasys Inc. Announces Financial Results for the Second Quarter of 2021
11 Aug 2021 16:05:01 By Nasdaq GlobeNewswire
-
Femasys Inc. Announces First Patient Treated in Pivotal Trial for FemaSeed
20 Jul 2021 08:31:36 By Nasdaq GlobeNewswire